Semaglutide by the Numbers:
In this data study, we examined the number of semaglutide clinics in each U.S. city and state. This study was conducted over a period of four months, from March to June 2024, involving approximately 120 hours of research and five SGS researchers.
The data below are updated continously as we revise our semaglutide and tirzepatide clinic database, currently the largest on the Internet. The key findings section is updated monthly.
Semaglutide is a medication used primarily for the treatment of type 2 diabetes and for chronic weight management. This versatile medication has shown significant efficacy in improving glycemic control and facilitating weight loss.[17]
It works by mimicking the hormone glucagon-like peptide-1 to enhance insulin secretion, suppress glucagon release, slow gastric emptying, and reduce appetite. It's marketed under several brand names:
Michael Nauck manages to infuse GLP-1 into people with type 2 diabetes, stimulating insulin while inhibiting glucagon and bringing blood glucose to normal levels. However, patients had significant side effects
